- Previous Close
0.1330 - Open
0.1330 - Bid 0.1170 x --
- Ask 0.1360 x --
- Day's Range
0.1330 - 0.1360 - 52 Week Range
0.0739 - 0.9480 - Volume
300,160 - Avg. Volume
208,134 - Market Cap (intraday)
20.613M - Beta (5Y Monthly) 1.19
- PE Ratio (TTM)
0.85 - EPS (TTM)
0.1600 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Miris Holding AB (publ) develops, manufactures, markets, and sells instruments and solutions for human milk analysis worldwide. The company offers Miris HMA, a human milk analyzer, used to analyze breast milk for individual nutrition of preterm babies; Miris Ultrasonic Processor, an ultrasonic liquid processor that homogenises milk and enables analysis of the true composition of the milk; and Miris Heater, a water free system that warms milk and other solutions to be injected to Miris human milk analyzer. It also provides Printers that automatically print the result off analysis as it appears on the Human Milk Analyzer screen; Miris Calibration Control Kit comprising two standardized solutions used to control the calibration of Miris Human Milk Analyzer; Miris Check used to zero set the analyser and control cleaning; and Miris Cleaner, a cleaning solution for the Human Milk Analyzer, as well as tubes and syringes. It serves neonatal intensive care units and milk banks, as well as researchers in public and private sectors. Miris Holding AB (publ) was founded in 2001 and is based in Uppsala, Sweden.
www.mirissolutions.com10
Full Time Employees
December 31
Fiscal Year Ends
Sector
Scientific & Technical Instruments
Industry
Recent News: MIR.ST
View MorePerformance Overview: MIR.ST
Trailing total returns as of 12/20/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: MIR.ST
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: MIR.ST
View MoreValuation Measures
Market Cap
20.61M
Enterprise Value
21.71M
Trailing P/E
0.86
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.70
Price/Book (mrq)
6.41
Enterprise Value/Revenue
1.30
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-45.33%
Return on Assets (ttm)
-24.89%
Return on Equity (ttm)
-287.12%
Revenue (ttm)
20.75M
Net Income Avi to Common (ttm)
-9.41M
Diluted EPS (ttm)
0.1600
Balance Sheet and Cash Flow
Total Cash (mrq)
1.46M
Total Debt/Equity (mrq)
200.39%
Levered Free Cash Flow (ttm)
-7.65M